Saturday, March 5, 2022

Hemophilia B Patients in China Fare Worse Than Those With Type A

Trial of Hemophilia B Gene Therapy BBM-H901 Begins Dosing in China. The study, “Medical costs and hospital utilization for hemophilia A and B ...
https://www.google.com/url?rct=j&sa=t&url=https://hemophilianewstoday.com/2022/03/04/longer-hospitalizations-higher-medical-costs-hemophilia-b-patients-china/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEJ2_dGeD9ytL28ALUv6b33TA3Osg
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...